| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c524ddcfa82c6028e82db2babeb98cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d58ff41c3702508ad98600fb1a9fb14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6126612cb6aaba8b0a71d9bf837f275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019e64d4045921838eb99b6c5c86817e |
| publicationDate |
2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160006916-A |
| titleOfInvention |
Treatment for the degenerative brain diseases mediated by Tau proteins |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating degenerative brain diseases mediated by tau protein comprising Egb 761 (Extract of Gingko biloba 761) as an active ingredient, and a screening method for treating a degenerative brain disease mediated by tau protein . Egb 761 effectively inhibits the phosphorylation of zinc-induced tau protein and ultimately can be used as an effective treatment for degenerative brain diseases mediated by tau protein. |
| priorityDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |